Enhanced antitumor immunotherapeutic effect of B-cell-based vaccine transduced with modified adenoviral vector containing type 35 fiber structures-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced antitumor immunotherapeutic effect of B-cell-based vaccine transduced with modified adenoviral vector containing type 35 fiber structures

Published:2013-11-14 Issue:1 Volume:21 Page:106-114
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Kim E-K,Seo H-S,Chae M-J,Jeon I-S,Song B-Y,Park Y-J,Ahn H M,Yun C-O,Kang C-Y

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201365.pdf

Reference45 articles.

1. Rosenberg SA, Yang JC, Restifo NP . Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10: 909–915.

2. Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ . Generation and functional characterization of mouse monocyte-derived dendritic cells. Eur J Immunol 1999; 29: 2835–2841.

3. Elkord E, Williams PE, Kynaston H, Rowbottom AW . Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 2005; 114: 204–212.

4. Gilboa E . DC-based cancer vaccines. J Clin Invest 2007; 117: 1195–1203.

5. Palucka K, Banchereau J . Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012; 12: 265–277.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of reactive oxygen species in inflammation and cancer;MedComm;2024-04

2. Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform;Proceedings of the National Academy of Sciences;2024-02-26

3. First-in-Human Phase 1 Study of a B Cell– and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer;Cancer Research and Treatment;2024-01-15

4. Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs;Frontiers in Immunology;2023-02-09

5. Immunotherapies against HER2-Positive Breast Cancer;Cancers;2023-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3